Analyst Ratings For Voyager Therapeutics (NASDAQ:VYGR)
Today, Voyager Therapeutics (NASDAQ:VYGR) stock was downgraded by Wedbush from Outperform to Neutral with a price target of $29.00.
Some recent analyst ratings include
- 3/12/2018-Wedbush was Downgraded by analysts at Wedbush from a “Outperform ” rating to a ” Neutral” rating. They now have a $29.00 price target on the stock.
- 3/11/2018-BTIG Research Reiterated Rating of Buy.
- 1/23/2018-Canaccord Genuity Reiterated Rating of Buy.
- 10/31/2017-Chardan Capital Reiterated Rating of Hold.
- 10/31/2017-Cowen Reiterated Rating of Buy.
Recent Insider Trading Activity For Voyager Therapeutics (NASDAQ:VYGR)
Voyager Therapeutics (NASDAQ:VYGR) has insider ownership of 8.00% and institutional ownership of 80.03%.
- On 2/27/2018 Dinah Ph.D. Sah, Insider, sold 15,623 with an average share price of $30.00 per share and the total transaction amounting to $468,690.00.
- On 2/12/2018 Bernard Ravina, Insider, sold 2,451 with an average share price of $18.24 per share and the total transaction amounting to $44,706.24.
- On 1/10/2018 Bernard Ravina, Insider, sold 3,630 with an average share price of $16.40 per share and the total transaction amounting to $59,532.00.
- On 12/11/2017 Bernard Ravina, Insider, sold 5,490 with an average share price of $13.63 per share and the total transaction amounting to $74,828.70.
- On 11/10/2017 Bernard Ravina, Insider, sold 5,490 with an average share price of $13.26 per share and the total transaction amounting to $72,797.40.
- On 10/10/2017 Bernard Ravina, Insider, sold 10,980 with an average share price of $20.33 per share and the total transaction amounting to $223,223.40.
- On 9/11/2017 Bernard Ravina, Insider, sold 16,470 with an average share price of $12.87 per share and the total transaction amounting to $211,968.90.
Recent Trading Activity for Voyager Therapeutics (NASDAQ:VYGR)
Shares of Voyager Therapeutics closed the previous trading session at 22.88 down -4.01 14.91% with 22.600000381469727 shares trading hands.
